Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis
Condition(s):Rheumatoid ArthritisLast Updated:October 30, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Rheumatoid ArthritisLast Updated:October 30, 2019Completed
Condition(s):BioequivalenceLast Updated:April 5, 2021Unknown status
Condition(s):Pain SyndromeLast Updated:February 14, 2022Completed
Condition(s):Healthy SubjectsLast Updated:September 8, 2022Completed
Condition(s):Pain, PostoperativeLast Updated:May 3, 2016Completed
Condition(s):Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis; Gout; ArthritisLast Updated:February 18, 2022Completed
Condition(s):Ossification, HeterotopicLast Updated:September 9, 2013Completed
Condition(s):Bioequivalence; Healthy SubjectsLast Updated:August 20, 2021Completed
Condition(s):Postherpetic Neuralgia; NeuralgiaLast Updated:March 23, 2011Unknown status
Condition(s):Cyclooxygenase Two Inhibitors; Etoricoxib; Periodontitis; Superoxide Dismutase; SalivaLast Updated:May 29, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.